Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
Remdesivir is a commonly used antiviral drug to treat COVID-19. Remdesivir has some side effects; however, whether it has any effect on cardiac is rarely reported. A 44-year-old woman with symptomatic confirmed COVID-19 was treated with intravenous remdesivir 200 mg on day one and followed with 100...
Main Authors: | Sidhi Laksono Purwowiyoto, Grace Trifena Hosea |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Universitas Muhammadiyah Surabaya
2022-07-01
|
Series: | Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya |
Subjects: | |
Online Access: | http://journal.um-surabaya.ac.id/index.php/qanunmedika/article/view/9379 |
Similar Items
-
Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study
by: Maryam Hajimoradi, et al.
Published: (2023-01-01) -
Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review
by: Fotios Barkas, et al.
Published: (2021-02-01) -
Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study
by: Yazed Saleh Alsowaida, et al.
Published: (2023-02-01) -
Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study
by: Homina Saffar, et al.
Published: (2024-12-01) -
Clinical outcomes and considerations in outpatient with COVID‐19 receiving remdesivir therapy
by: Zeinab Siami, et al.
Published: (2024-07-01)